Biotechnology · DeepTech · Health
1 - 10 employees
Our vision is to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. Currently, there is no readily available solutions to address blood levels of anticoagulants called Direct Oral Anticoagulants (DOACs) at the point-of-care. We have developed a novel technology, chip and instrument that can detect anticoagulants, directly from whole blood within only 10 minutes. The elegant simplicity of our solution will potentially be readily available at the point of care.Something looks off?